NPI registry status
Active
2026 NPPES data Specialist NPI 1336198407 MD
Verify on CMS → Rene Cabeza, MD
Specialist in Orange City, Florida.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 69,567 in Specialist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 238 beneficiaries · Specialist avg: 2K
Generic prescribing
55%
generic claims · 45% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
100/100
▲ 17 pts above national avg 83.5 · Exceptional
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Rene Cabeza, MD reported a CMS MIPS final score of 100/100 - above the 83.5 national average - and filed 1,271 Medicare Part D claims in 2024.
- 100/100
- MIPS score · +17 vs avg
- 1K
- Part D claims, 2024
- 55%
- generic prescribing
- ≥92nd
- pct among measured MIPS (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Rene Cabeza, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1336198407), first enumerated 05/08/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,271 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 100/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- State context
State board disciplinary context
Florida statewide board action statistics are published annually — these figures describe aggregate state activity, not Rene Cabeza, MD's individual license status. Verify directly with the state medical board.
Source: FLDOH annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1336198407 · Specialist
NPI-10 · ENUM-LEGACY · TAX-MEGA · MIPS-ELITE · RX-MID · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1336198407
- ENUM-LEGACY 2006
- TAX-MEGA 70K Specialist
- MIPS-ELITE 100/100
- RX-MID 1,271
- BOOK-LIGHT 3,439 in Florida
- PHOTO-FINISH Mahta Baghoolizadeh · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Cabeza · this pr…
Cabeza · this provider
100 MIPS pts
- Samuel Bledsoe ·…
Samuel Bledsoe
100 MIPS pts
- Mahta Baghooliza…
Mahta Baghoolizadeh
100 MIPS pts
- Barry Baron · near
Barry Baron
100 MIPS pts
- George Bensch · …
George Bensch
100 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Rene Cabeza, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
100 ≥ 92nd percentile 92% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Rene Cabeza, MD sits
This provider among specialist peers
Across the 4,261 specialist providers who report both Medicare Part D prescribing and a MIPS quality score, Rene Cabeza, MD writes more Part D claims than 61% of them and scores higher on MIPS quality than 90% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one specialist peer from a representative sample of 60; the gold marker is Rene Cabeza, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
What does the federal data show about Rene Cabeza, MD?
High performer (top quartile)Primary specialty
Specialist
Medicare Part D claims
1,271 17% vs specialty avg
MIPS final score
100/100 16.5 pts vs avg
Specialty distribution in Florida
How Specialist compares to other specialties among Florida providers
Medicare quality performance, MIPS
Rene Cabeza, MD's 2023 MIPS final score plotted against the Specialist national average
- MIPS Final Score
- 100/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1336198407 |
|---|---|
| Specialty | Specialist |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 05/08/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
100
Final Score
Measured-score avg: 83.5
95.3636
Quality
97.0724
Cost
Reporting: Group practice
Hospital and facility affiliations
Facilities where Rene Cabeza, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Mid-Florida Cancer Centers LLC
Orange City, FL
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
License & disciplinary context - Florida FLDOH 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to Rene Cabeza, MD. To verify Rene Cabeza, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Rene Cabeza, MD - brand share 45.0%
Specialist average
45% brand-name claims vs 55% generic, on 1,271 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
1,271
Total Claims
$3.8M
Total Drug Cost
238
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 2,030.233
- Total Day Supply
- 56,195
- Brand vs Generic
- 45% brand / 55% generic
- Brand Drug Cost
- $2.9M
- Generic Drug Cost
- $900K
- Opioid Claims
- 53 (4.2% rate)
- Antibiotic Claims
- 23
Patient Demographics
- Average Patient Age
- 74.4 years
- Avg HCC Risk Score
- 2.32
- Gender Split
- 64% female / 36% male
- Age Distribution
- <65: 24, 65-74: 93, 75-84: 86, 85+: 35
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Rene Cabeza, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Eliquis
Eliquis
182 claims
- Anastrozole 66
Anastrozole
66 claims
- Lenalidomide 60
Lenalidomide
60 claims
- Procrit 57
Procrit
57 claims
- Warfarin Sodium 48
Warfarin Sodium
48 claims
- Xarelto 45
Xarelto
45 claims
- Dexamethasone 36
Dexamethasone
36 claims
- Darzalex Faspro 30
Darzalex Faspro
30 claims
| Drug | Claims |
|---|---|
| Eliquis Apixaban | 182 |
| Anastrozole | 66 |
| Lenalidomide | 60 |
| Procrit Epoetin Alfa | 57 |
| Warfarin Sodium | 48 |
| Xarelto Rivaroxaban | 45 |
| Dexamethasone | 36 |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 30 |
| Hydroxyurea | 30 |
| Prolia Denosumab | 30 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Specialist Overview
How Rene Cabeza, MD fits within the Specialist landscape nationally.
69,567
Specialist Providers in US
55
States with Specialist
1,524
Avg Claims per Provider
Rene Cabeza, MD's 1,271 claims are below the specialty average of 1,524.
Nationwide Specialist peers with similar MIPS or enrollment year
Two federal-record peer sets for Cabeza, both outside Florida so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (100 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Specialist Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Cabeza.
One of 3,439 Specialist providers enrolled in Florida, 5 are shown here.
Dr. Cory Abbate
DPT
North Miami, FL
David Abbott
Clearwater, FL
Dr. Michael Abdoney
DDS
Tampa, FL
Dr. Syed Abid
MD
St Petersburg, FL
Dr. Shagen Abovyan
MD
Fort Lauderdale, FL
Compare Specialist nationally: see state-by-state distribution →
Frequently Asked Questions
What is Rene Cabeza, MD's specialty? ▼
Rene Cabeza, MD specializes in Specialist and practices in Orange City, Florida. Credentials: MD.
How much does Rene Cabeza, MD prescribe under Medicare Part D? ▼
In 2024, Rene Cabeza, MD wrote 1,271 Medicare Part D claims totaling $3.8M in drug costs for 238 beneficiaries.
What is Rene Cabeza, MD's Medicare quality score? ▼
Rene Cabeza, MD has a CMS MIPS Final Score of 100/100 (Quality: 95.4, Cost: 97.1). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Rene Cabeza, MD located? ▼
Rene Cabeza, MD is located at 2776 ENTERPRISE RD, Orange City, FL, 32763. Phone: (386) 774-1223.
What is Rene Cabeza, MD's NPI number? ▼
Rene Cabeza, MD's National Provider Identifier (NPI) is 1336198407, issued on 05/08/2006.
Does Rene Cabeza, MD prescribe more brand-name or generic drugs? ▼
Rene Cabeza, MD's prescribing is 45% brand-name and 55% generic drugs by claim count, with $2.9M in brand drug costs.
Does Rene Cabeza, MD prescribe opioids? ▼
Yes, Rene Cabeza, MD had 53 opioid claims in 2024 with an opioid prescribing rate of 4.2%.
How many Specialist providers are there in the US? ▼
There are 69,567 Specialist providers across 55 states in the US. The average Specialist provider writes 1,524 Medicare Part D claims per year.
What drugs does Rene Cabeza, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Rene Cabeza, MD's most frequently prescribed drugs include Eliquis, Anastrozole, Lenalidomide. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Rene Cabeza, MD accept Medicare? ▼
Rene Cabeza, MD appears in CMS Medicare data with 1,271 Part D claims and 238 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Rene Cabeza, MD's credentials? ▼
Rene Cabeza, MD's NPI is 1336198407 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.